It was suggested that levels of soluble TRAIL in human plasma were approximately 28 pg/mL [52], a concentration at which TRAIL is insufficient for effective induction of apoptosis in lung cancer, colorectal cancer, and pancreatic cancer [53]. This evidence concerns the gene TNFSF10 and colorectal cancer.